Loading...
•
Dec 31, 2025
Brightspring Health Services Inc Q4 2025 Earnings Report
Brightspring Health Services Inc reported strong fourth quarter 2025 results with significant revenue growth, margin expansion, and sharply higher net income year over year.
Key Takeaways
BrightSpring delivered strong Q4 2025 performance with 29.3% revenue growth, a substantial increase in operating income, and net income rising to $49.6 million from $4.3 million a year ago, driven by solid performance in both Pharmacy Solutions and Provider Services.
Total revenue increased 29.3% year over year to $3550631000.
Operating income nearly doubled to $108113000.
Net income from continuing operations rose to $49551000 from $4282000.
Adjusted EBITDA grew 40.7% year over year to $183548000.
Revenue by Segment
Forward Guidance
For full year 2026, BrightSpring expects revenue between $14450000000 and $15000000000 and Adjusted EBITDA between $760000000 and $790000000, excluding Community Living and future acquisitions.
Positive Outlook
- Projected total revenue growth of 11.9% to 16.2%.
- Pharmacy segment revenue expected to grow 10.1% to 14.5%.
- Provider segment revenue expected to grow 26.3% to 29.7%.
- Adjusted EBITDA expected to grow 23.1% to 27.9%.
- Amedisys and LHC acquisition expected to contribute approximately $30000000 in Adjusted EBITDA.
Challenges Ahead
- Guidance excludes future acquisitions.
- Community Living business excluded from guidance.
- Adjusted EBITDA is a non-GAAP metric without GAAP reconciliation.
- Exposure to reimbursement rate changes.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...